Follow

The drug reduces a growth-promoting hormone that is believed to be the reason larger dogs have much shorter life spans than smaller breeds. The fast-tracked approval will make the drug available on the market by 2026. themessenger.com/news/dogs-exp

Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.